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Background: Primary adenocarcinoma of thymus is extremely rare.
Case presentation: This is a case of primary adenocarcinoma with intestinal differentiation and focal mucin
production in the thymus. Thymic cyst was associated with this tumor. Intestinal differentiation was confirmed by
immunohistochemical stain with positivity for CDX-2, CK20, villin, MOC31 and focal positivity of CK7. Array
comperative genomic hybridization (CGH) analysis showed a complex pattern of chromosomal imbalances
including homozygous deletion at the HLA locus in chromosomal region 6p21.32.
Conclusion: This rare tumor shows a similar genetic aberration with other studied thymic epithelial tumors.
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Primary thymic carcinomas are very rare tumors. The
most common histologic subtypes are squamous cell,
adenosquamous/mucoepidermoid, basal cell, large cell
undifferentiated, adenocarcinoma, carcinoma with ade-
noid cystic carcinoma-like features, lymphoepithelioma-
like, clear cell, and sarcomatoid carcinomas [1]. Primary
thymic adenocarcinoma was first reported in 1989 [2]
but has not been accepted as a valid histologic subtype
until 1997 [3]. These are uncommon neoplasms. Papil-
lary adenocarcinoma and mucinous adenocarcinoma are
the most common variants [1,4-6]. Therefore, before a
diagnosis of a de novo thymic adenocarcinoma, other pos-
sible diagnoses such as: metastatic carcinoma, thymoma
and adenocarcinoma arising in a mediastinalteratoma
should be excluded [1,7]. There is little genetic data for
thymic carcinomas other than squamous cell carcinomas
[8], so we applied a genetic study by array comperative
genomic hybridization (CGH) analysis on this case.* Correspondence: y@daneshbod.com
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Shiraz, Iran
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distribution, and reproduction in any mediumCase presentation
A 28 year old woman presented with neck and right
upper extremity pain accompanied by dyspnea of two
years duration. Chest X- ray revealed mediastinal widen-
ing (Figure 1A). Chest computed tomography (CT) scan
(Figure 1B) showed an anterior mediastinal mass invad-
ing in pericardium without extramediastinal extension.
An initial clinical impression of a mediastinal germ cell
tumor was considered but serum tumor markers such as
alpha-feto protein (AFP), Beta-human chorionic gonado-
tropin (β-hCG), carcinoembryonic antigen (CEA) and
CA-125 were normal. CA19-9 level was 2420 U/ml (nor-
mal: 0.37U/ml). A mediastinal biopsy was done and
showed histologic features of adenocarcinoma. Endos-
copy, colonoscopy, abdominopelvicsonography and im-
aging studies were negative for primary origin. The
patient underwent mid-sternotomy. The mass was
resected. The patient received chemotherapy (GEMOX)
and radiotherapy with two recurrences in 2 years follow
up. She is doing well and free of tumor after 6 months.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Representative images of radiology, histology, immunostaining as well as results of array-comparative genomic hybridization
(array-CGH). A: Chest X ray showed mediastinal widening. B: chest CT scan revealed anterior mediastinal mass that invade pericardium.
C: tumoral sheets and glandular structures in desmoplasticstroma (H&E stain, × 400). D: Malignant glands showed diffuse membranous positivity
for CD5. (Immunoperoxidase). E: nuclear positivity for CDX-2 in malignant glands (Immunoperoxidase). F: Malignant glands showed diffuse
positivity for CK20 (Immunoperoxidase). G: benign columnar linningthymic cyst adjacent to neoplastic glands (H&E stain, × 200). H: neoplastic
glands arising in the vicinity of thymic cyst (H&E stain, × 200). I: Array-CGH-results displayed in a whole genome view showed deletion of
chromosome 6. J: Homozygously deleted region around the HLA-DRB5-locus in chromosomal region 6p21.32.
Table 1 Comercial sources, clones, and working dilutions
of antibodies used in this case
Antibody Dilution Clone Vendor
HMWK Ready to use 34 βE12 Novocastra, New Castle, UK
EMA Ready to use GP1.4 Novocastra, New Castle, UK
CK Ready to use AE1/AE3 Novocastra, New Castle, UK
CK20 Ready to use PW31 Novocastra, New Castle, UK
CDX-2 1: 100 AMT28 Novocastra, New Castle, UK
CK7 Ready to use RN7 Novocastra, New Castle, UK
CD5 Ready to use 4C7 Novocastra, New Castle, UK
Villin 1: 200 CWWB1 Novocastra, New Castle, UK
MOC31 1: 50 MOC31 Novocastra, New Castle, UK
ER Ready to use 6 F11 Novocastra, New Castle, UK
PR Ready to use 16 Novocastra, New Castle, UK
TTF-1 1: 200 SPT24 Novocastra, New Castle, UK
GCDFP-15 Ready to use 23A3 Novocastra, New Castle, UK
P63 1: 25 7JUL Novocastra, New Castle, UK
CD30 Ready to use JCM182 Novocastra, New Castle, UK
PLAP Ready to use 8A9 Novocastra, New Castle, UK
Chromogranin Ready to use 5H7 Novocastra, New Castle, UK
CD117 Ready to use T595 Novocastra, New Castle, UK
Calretinin 1: 200 CAL6 Novocastra, New Castle, UK
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The mediastinal biopsy showed a moderately differentiated
adenocarcinoma with a desmoplastic and necrotic stroma
(Figure 1C). Scattered small mucinous lakes were noted in
the stroma. The stroma also showed foci of calcification
and occasional psammoma bodies. Intracytoplasmic and
stromal positive reactions were seen on mucicarmin stain.
The excised tumor showed similar morphological and im-
munohistochemical characteristics. In one of the sections,
a unilocunar large cyst with columnar epithelium, in vicin-
ity of the tumor was also identified (Figure 1G, H). Small
foci of remnant of thymic tissue were identified. Immuno-
histochemical (IHC) study showed positivity for CK, EMA,
CK20 (Figure 1D), CDX-2 (Figure 1E), CK7, CD5
(Figure 1F), villin, HMWK(focal) and MOC31 but ER, PR,
TTF-1, GCDFP-15, P63, CD30, PLAP, chromogranin,
calretinin and CD117 were all negative. Commercial
sources, clones, and working dilutions of antibodies used
in the study are listed in Table 1. Extensive histologic and
immunohistochemical study of the whole specimen
showed no evidence of teratomatous or germ cell
elements.
Genetic abberations in formalin-fixed paraffin-embedded
tissue
Array CGH on this case was performed using the
Human Genome Microarray 180A platform (Agilent,
Santa Clara, USA). The experimental procedures were
performed according to the protocols provided by the
Table 2 Literature review of clinicopathological data of primary thymic adenocarcinomas
Author Year Sex Age Symptoms Tumor type Site RX Outcome Associated findings
Moriyama S [2] 1989 F 51 Hyperthyroidism Papillo-tubular
Right lobe of the
thymus
S No recurrence for 14 years Multiple thymic cysts
Babu MK [19] 1994 M 50 NA Conventional NA Alive after 4 months Congenital thymic cyst
Makino Y [6] 1998 M 39 Chest pain Papillary carcinoma NA S,R Alive after 5 months NA
Matsuno [5] 1998
M 70 Not mentioned Papillary carcinoma Anterior mediastinum S,R Recurrence after 8 months Numerous psammoma bodies
F 69 Not mentioned Papillary carcinoma
Left lower pole of the
thymus
S Not mentioned Thymoma of medullary type
F 61 Not mentioned Papillary carcinoma
Substernalmediastinal
mass
S,R,C Died after 7 months
Chronic elephantiasis
nostrasverrucosum in skin
M 57 Not mentioned Papillary carcinoma Anterior mediastinum S,R,C Alive after 5 years No
Shimono [20] 2001 M 61 facial edema, general fatigue Not specified Anterior mediastinum S,R,C Alive after 53 months No
Zaitlin [21] 2003 F 51 Asymptomatic Papillary carcinoma
Anterior left
mediastinum
S,R Died after 26 months Thymic cyst
Choi WW [7] 2003
M 39 Cough&lethargy Papillary carcinoma Anterior mediastinum S,R,C Alive after 3 years NA
M 15 Dry cough Mucinous carcinoma
Right anterior
mediastinum
S,R Died after 26 months
Thymiccyst&cribriform,
carcinomatous gland in thymic
medulla
Misao [10] 2004 M 59
Accidental finding in
chest x ray
Not specified Anterior Mediastinum S,C Died after 24 months No
Takahashi F [1] 2004 M 49
Accidental finding in
chest x ray
Mucinous carcinoma Anterior mediastinum R Died 11 months after DX Increased CA19-9, CEA




Alive in 11 months after
surgery.
No
Yoshino M [12] 2005 F 29
Accidental finding in
chest x ray
Papillary carcinoma Anterior mediastinum S Not mentioned
Type A thymoma, Psammoma
bodies and follicles
PayalKapur [4] 2006 M 41 Not mentioned Mucinous carcinoma Anterior mediastinum R,c 2 recurrence in 3 years Multiple thymic cysts








Lung metastasis after eight
months of surgery
Increased CA19-9, CEA
Seong H. Ra [13] 2007
F 61
Hoarseness, dysphagia,












chest tightness, back stiffness,
and weight loss of 15 lb
Mucinous carcinoma Anterior mediastinum S




Furtado [14] 2008 M 44
Accidental finding in
chest x ray
Papillary carcinoma Pretracheal region S,R,C Alive for 24 months Psammoma bodies




























Table 2 Literature review of clinicopathological data of primary thymic adenocarcinomas (Continued)









Passed away 56 days
after the initialsymptoms
Slight elevation of sialyl Lewis-
x antigen,soluble interleukin-2
receptor
Maeda D [17] 2009
F 52
Bulging of the left
parasternal region




M 38 Chest pain Mucinous carcinoma Anterior mediastinum S,R,C
Died 12 months after
diagnosis
No
M 55 Chest tightness Mucinous carcinoma Anterior mediastinum S,R,C
Died 24 months after
diagnosis
No
Yong Joon Ra [18] 2010 M 68
Dyspnea and chest




Not mentioned Slightly increased (β-hCG) level
Current case 2010 F 28
Neck and right upper
extremity pain and dyspnea
Mucinous Anterior mediastinam S,R,C
Two recurrences in two
years follow up
Thymic cyst and psammoma
bodies, increased CA19-9


































Associated serum tumor markers
CEA B-HCG AFP CA19-9
Papilotubular 2 1 52.5 1 0 0
Conventional 3 3 50.6 1 0 0 1 1
Papillary 10 1.5 49.5 1 3 3 1 1
NOS 2 2 60 0 0 0 1 1
Mucinous 9 2 50.2 4 0 1 3 1
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Microarray Scanner (Agilent) at a scan resolution of
5 μm. Signal intensities from the generated images were
measured and evaluated with Feature Extraction 10.10.11
and Agilent Genomic Standard Workbench Edition
6.5.0.58 (AGW6.5) software (Agilent) applying the Aber-
ration Detection Method-2 (ADM-2) algorithm with a
threshold of 6.0. It showed a complex karyotype with
multiple gains and losses. Part of the HLA-DR5 locus in
chromosomal region 6p21.32 seemed to be homozy-
gously deleted (Figure 1I, J).Consent
“Written informed consent was obtained from the pa-
tient for publication of this case report and any accom-
panying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.”Discussion
Metastatic neoplasms to the mediastinum account for
most of epithelial cell neoplasms. The second most com-
mon tumors are thymoma and thymic carcinoma. Pri-
mary adenocarcinoma is very rare in mediastinum, so
before considering this diagnostic entity, most prevalent
tumors such as metastatic adenocarcinomas, germ cell
tumors and malignant teratomas must be ruled out
[1,3-5,7,8]. Through clinical history, imaging studies, ab-
sence of extramediastinal tumor and histology, we report
a case of primary adenocarcinoma with intestinal differ-
entiation of the thymus with mucin production.
Immunostains are an important tool in the study of
mediastinal tumors. For instance CD5 is a leukocyte
marker expressed on differentiating thymocytes. It is
said to be useful in differentiating thymic from non-
thymic carcinomas [4,7,8]. Caution must be given be-
cause CD5 is positive in malignant pleural mesothelioma
and adenocarcinomas of other (non thymic origin) or-
gans [4,8]. It is also important to exclude tumors derived
from the lung and pleura by evaluating TTF-1 and
calretinin.The exact origin of thymic adenocarcinoma is not
clear. Glandular differentiation is rarely seen in ultra-
structural studies of normal thymic epithelial cells [5].
Also, in the involuted thymus, glandular or tubular
structures can be found [7]. Therefore, adenocarcinomas
can result from extreme glandular differentiation during
tumor progression.
Review of the literature on thymic adenocarcinoma is
shown in Tables 2 and 3. Twenty-six cases have been
reported. Patients range in age from 15 to 82 years
(mean 50 y ±17 y). Male/female ratio is 1.9/1. The most
common morphologic subtypes are papillary carcinoma
(38%), mucinous adenocarcinoma (34%), conventional
adenocarcinoma (0.11%), NOS (0.07%) and papilotubular
carcinoma (0.07%). Median age is 52.56 years. Associ-
ated findings are thymic cyst in 26% (mostly seen in mu-
cinous subtype), thymoma in 11% (only in papillary
subtype) and psammoma bodies in 15% (mostly seen in
papillary subtype). Serum tumor markers were increased.
CEA in 23% (mostly seen in mucinous subtype), B-HCG
in 0.38% (only in conventional subtype) and CA19-9 in
11% (one papillary, one NOS and two mucinous sub-
types, including ours). Immunohistochemistry on differ-
ent subtypes were performed in a limited number of
papers and showed positivity in CK7 (7/11), CK20 (6/9),
CEA (6/9), Leu M1 (4/5), B-HCG (1/2), CDX-2 (3/4),
Muc2 (1/2), Muc5 (2/2), CD5 (8/12), P63 (1/2), CA-19-9
(3/3), CAM5.2 (2/2), CK5,6 (1/2), P53 (2/2), Her2 (1/2)
[4-7,9-18].
In our case the adenocarcinoma was associated with a
large benign thymic cyst with columnar epithelium. It
showed no dysplastic change.
Most of the patients with thymic adenocarcinoma do
not have any chief complaint (41%). In symptomatic
group, the most common presenting sign is chest pain
(0.17%). Other rare signs are cough (0.05%), dyspnea
(0.05%), and shoulder pain (0.05%). Weight loss is a rare
sign in this tumor (0.05%). Anterior mediastinum is the
most common location (79%) followed by right, left,
substernal and pretracheal mediastinum (each below%1).
Prognosis cannot be accurately evaluated due to low in-
cidence rate of thymic adenocarcinoma. Some patients
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(12 cases) or radiotherapy (19 cases). Clinical outcome
showed local recurrences (2 cases), metastatic disease
(3 cases) and death due to surgical complication or dis-
ease (9 cases). According to Table 3, mucinous has much
worse prognosis than papillary carcinoma (p value < 0.05).
There are diverse genetic heterogenecity in thymic tu-
mors. Genetic characterization has concentrated on WHO
types A, B3, and C that harbors few lymphocytes [22]. No
chromosomal gain is seen in type A and AB thymomas
[8]. Simultaneous gain of 1q and loss of chromosome 6,
and 13q aberrations frequently detected in type B3 thym-
omas. Loss of heterozygosity (LOH) on chromosome 6 is
the most frequent genetic abnormality in thymoma.
Recent studies on genetic alterations of thymoma based
on (LOH) analyses inferred two different genetic pathways
of tumorigenesis of thymoma, and heterogeneous genetic
alterations in subtypes of thymoma, were identified by
CGH and LOH analyses [22,23]. One of the important
findings in the thymic epithelial tumor is frequent and
multiple genetic aberrations of chromosome 6 that are
found in 77.5 percent of them. There are five hotspots of
frequent deletions indicating that several putative tumor
suppressor genes on chromosome 6 are involved in the
development of thymic epithelial tumor [8,22,23]. Deletion
sites such as 6q21, 6q23, and 6q25-27 are well established
in thymoma. As Zhou et al. reported; the most frequent
LOH was found in the 6q23.3-25.3 chromosomal region
and the second hot spot of deletions was located in the
6p21 region containing the major histocompatibility
(MHC) classes I and II gene loci [22,24].
In our case, the HLA-DRB5-locus in chromosomal re-
gion 6p21.32 was homozygously deleted, showing similar
genetic aberrations with other thymic epithelial tumors.
Conclusion
This primary adenocarcinoma of the thymus with intes-
tinal differentiation shows homozygous deletion of part
of the HLA- locus in chromosomal region 6p21.32 con-
firmed by CGH array. It is associated with a benign
thymic cyst. This is the first genetic study on a primary
thymic adenocarcinoma (mucinous type), which shows a
similar genetic aberration with other thymic epithelial
tumors. We suggest adding genetic study to clinicopath-
ologic and imaging workup for confirmation of diagnosis
of a primary thymic tumor.
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